By Drug Target Review2023-09-01T10:00:39
Researchers have shown insights into the omicron variants of the SARS-CoV-2 virus, which have rapidly disseminated globally in the past year.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-01-23T13:30:34Z
2026-01-20T13:30:29Z
2023-04-04T15:03:09
Sponsored by Agilent
2023-11-24T12:06:45
Sponsored by Quantum-Si
2023-07-11T16:13:06
Sponsored by Agilent
2023-03-07T10:55:58
Sponsored by Agilent
2023-07-04T10:05:58
Sponsored by Revvity
Site powered by Webvision Cloud